Verrica Pharmaceuticals

CompanyUnited StatesFounded 2013

Verrica Pharmaceuticals develops one asset, approved (cantharidin in Molluscum Contagiosum). Mostly small molecule; based in the United States, founded in 2013.

1
Asset
Furthest stage
Approved
Raised
$123M
2
Trials
1
Signal

Pipeline

1
  • cantharidin

    Topical cellular vesicant causing blistering of the skin

    Approved, Small molecule, Molluscum Contagiosum, common wart (Phase 3)

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials2
  • Funding rounds and grants7
  • People10
  • Signals3
  • Similar companies2

Intelligence